As of Jan 13
| +0.05 / +0.94%|
The 2 analysts offering 12-month price forecasts for Juniper Pharmaceuticals Inc have a median target of 10.88, with a high estimate of 15.00 and a low estimate of 6.75. The median estimate represents a +103.27% increase from the last price of 5.35.
The current consensus among 2 polled investment analysts is to Buy stock in Juniper Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.